Royalty Pharma plc Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Green day on Monday for Royalty Pharma plc stock after gaining 0.282%
(Updated on May 06, 2024)
The Royalty Pharma plc stock price gained 0.282% on the last trading day (Monday, 6th May 2024), rising from $28.41 to $28.49. During the last trading day the stock fluctuated 1.30% from a day low at $28.36 to a day high of $28.73. The price has risen in 6 of the last 10 days and is up by 2.41% over the past 2 weeks. Volume fell on the last day by -339 thousand shares and in total, 2 million shares were bought and sold for approximately $48.47 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.53% during the next 3 months and, with a 90% probability hold a price between $24.89 and $27.19 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
RPRX Signals & Forecast
There are mixed signals in the stock today. The Royalty Pharma plc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $28.94. On a fall, the stock will find some support from the short-term average at $28.22. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, May 02, 2024, and so far it has fallen -0.94%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. The stock had a Golden Star Signal on Thursday, December 28, 2023 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Golden Star 12 Months
The stock had a Golden Star Signal on Thursday, December 28, 2023 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Support, Risk & Stop-loss for Royalty Pharma plc stock
Royalty Pharma plc finds support from accumulated volume at $28.12 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.370 (1.30%) between high and low. For the last week, the stock has had daily average volatility of 1.94%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (RPRX) For The Upcoming Trading Day Of Tuesday 7th
For the upcoming trading day on Tuesday, 7th we expect Royalty Pharma plc to open at $28.53, and during the day (based on 14 day Average True Range), to move between $27.91 and $29.07, which gives a possible trading interval of +/-$0.580 (+/-2.04%) up or down from last closing price. If Royalty Pharma plc takes out the full calculated possible swing range there will be an estimated 4.07% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $28.12 (1.30%) than the resistance at $29.05 (1.97%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Royalty Pharma plc will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is $0.96. We will update the financials statements for Royalty Pharma plc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.64% in the first trading day after earnings release.
Is Royalty Pharma plc stock A Buy?
Royalty Pharma plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.817 Sell Candidate Unchanged
Predicted Opening Price for Royalty Pharma plc of Tuesday, May 7, 2024
| Fair opening price May 7, 2024 | Current price |
|---|---|
| $28.53 ( 0.129%) | $28.49 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for RPRX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 28.90 | 1.43 % | |
| R2 | 28.76 | 0.93 % | ||
| R1 | 28.67 | 0.625 % | ||
| Current price: | 28.49 | |||
| Support | S1 | 28.39 | -0.367 % | |
| S2 | 28.30 | -0.674 % | ||
| S3 | 28.16 | -1.17 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 31.23 | 9.62 % | |
| R2 | 30.37 | 6.60 % | ||
| R1 | 29.05 | 1.97 % | ||
| Current price | 28.49 | |||
| Support | S1 | 28.12 | -1.30% | |
| S2 | 28.07 | -1.47% | ||
| S3 | 27.82 | -2.35% |
RPRX Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Apr 17, 2024 | May 16, 2024 | Jun 14, 2024 | $0.210 | 0.737% |
| 2 | Feb 15, 2024 | Feb 15, 2024 | Mar 15, 2024 | $0 | 0% |
| 3 | Oct 16, 2023 | Nov 16, 2023 | Dec 15, 2023 | $0.200 | 0.731% |
| 4 | Jul 17, 2023 | Aug 17, 2023 | Sep 15, 2023 | $0.200 | 0.711% |
| 5 | Apr 17, 2023 | May 18, 2023 | Jun 15, 2023 | $0.200 | 0.621% |
FAQ
Click here for our free guide on how to buy Royalty Pharma plc Stock.
